Invasive micropapillary carcinoma of the breast: an immunohistochemical study of neoplastic and stromal cells. 2005

Naoto Kuroda, and Takeki Sugimoto, and Tamotsu Takahashi, and Toshiaki Moriki, and Makoto Toi, and Eriko Miyazaki, and Makoto Hiroi, and Hideaki Enzan
Department of Pathology, Kochi Medical School, Kochi, Japan.

A 59-year-old woman complained of a palpable mass in the right breast, and a needle biopsy disclosed small clusters of neoplastic cells in the fibrous stroma. The small clusters did not contain fibrovascular cores but exhibited micropapillary configuration. Epithelial membrane antigen (EMA) immunohistochemistry confirmed the reverse polarity of the neoplastic cells. Additionally, the plasma membrane of many neoplastic cells stained with E-cadherin and beta-catenin. Myofibroblasts, which were positive for alpha smooth muscle actin (ASMA) and negative for cytokeratin 14, were abundant in the neoplastic stroma, but no CD34-positive stromal cells were observed in the neoplastic stroma. For comparison, 3 additional cases of invasive micropapillary carcinoma (IMC) and 4 cases of invasive ductal carcinoma (IDC) were studied. Similar results for stromal cells were obtained in all cases. Our results from this preliminary investigation suggest that CD34-positive stromal cells may disappear from the stroma of IMC as well as IDC.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002291 Carcinoma, Papillary A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed) Carcinomas, Papillary,Papillary Carcinoma,Papillary Carcinomas
D003598 Cytoskeletal Proteins Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible. Proteins, Cytoskeletal
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000199 Actins Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments (known also as filamentous or F-actin) can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-actin. In conjunction with MYOSINS, actin is responsible for the contraction and relaxation of muscle. F-Actin,G-Actin,Actin,Isoactin,N-Actin,alpha-Actin,alpha-Isoactin,beta-Actin,gamma-Actin,F Actin,G Actin,N Actin,alpha Actin,alpha Isoactin,beta Actin,gamma Actin
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015534 Trans-Activators Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins. Nuclear Trans-Acting Factor,Trans-Acting Factors,Trans-Acting Factor,Trans-Activator,Transactivator,Transactivators,Factor, Nuclear Trans-Acting,Factor, Trans-Acting,Factors, Trans-Acting,Nuclear Trans Acting Factor,Trans Acting Factor,Trans Acting Factors,Trans Activator,Trans Activators,Trans-Acting Factor, Nuclear

Related Publications

Naoto Kuroda, and Takeki Sugimoto, and Tamotsu Takahashi, and Toshiaki Moriki, and Makoto Toi, and Eriko Miyazaki, and Makoto Hiroi, and Hideaki Enzan
July 2006, International journal of urology : official journal of the Japanese Urological Association,
Naoto Kuroda, and Takeki Sugimoto, and Tamotsu Takahashi, and Toshiaki Moriki, and Makoto Toi, and Eriko Miyazaki, and Makoto Hiroi, and Hideaki Enzan
February 2004, Pathology international,
Naoto Kuroda, and Takeki Sugimoto, and Tamotsu Takahashi, and Toshiaki Moriki, and Makoto Toi, and Eriko Miyazaki, and Makoto Hiroi, and Hideaki Enzan
December 2007, Medical molecular morphology,
Naoto Kuroda, and Takeki Sugimoto, and Tamotsu Takahashi, and Toshiaki Moriki, and Makoto Toi, and Eriko Miyazaki, and Makoto Hiroi, and Hideaki Enzan
August 2010, Japanese journal of clinical oncology,
Naoto Kuroda, and Takeki Sugimoto, and Tamotsu Takahashi, and Toshiaki Moriki, and Makoto Toi, and Eriko Miyazaki, and Makoto Hiroi, and Hideaki Enzan
August 2016, Archives of pathology & laboratory medicine,
Naoto Kuroda, and Takeki Sugimoto, and Tamotsu Takahashi, and Toshiaki Moriki, and Makoto Toi, and Eriko Miyazaki, and Makoto Hiroi, and Hideaki Enzan
February 1990, Pathology, research and practice,
Naoto Kuroda, and Takeki Sugimoto, and Tamotsu Takahashi, and Toshiaki Moriki, and Makoto Toi, and Eriko Miyazaki, and Makoto Hiroi, and Hideaki Enzan
December 2020, Breast cancer research and treatment,
Naoto Kuroda, and Takeki Sugimoto, and Tamotsu Takahashi, and Toshiaki Moriki, and Makoto Toi, and Eriko Miyazaki, and Makoto Hiroi, and Hideaki Enzan
November 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Naoto Kuroda, and Takeki Sugimoto, and Tamotsu Takahashi, and Toshiaki Moriki, and Makoto Toi, and Eriko Miyazaki, and Makoto Hiroi, and Hideaki Enzan
October 2005, Archives of pathology & laboratory medicine,
Naoto Kuroda, and Takeki Sugimoto, and Tamotsu Takahashi, and Toshiaki Moriki, and Makoto Toi, and Eriko Miyazaki, and Makoto Hiroi, and Hideaki Enzan
June 2017, Oncotarget,
Copied contents to your clipboard!